Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Duration of Pediatric Clinical Trials Submitted to the US Food and Drug Administration

Published:2019-01-01 Issue:1 Volume:173 Page:60
ISSN:2168-6203
Container-title:JAMA Pediatrics
language:en
Short-container-title:JAMA Pediatr

Author:

Zimmerman Kanecia O.¹²,Smith P. Brian¹²,McMahon Ann W.³,Temeck Jean³,Avant Debbie³,Murphy Dianne³,McCune Susan³

Affiliation:

1. Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina

2. Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina

3. Office of Pediatric Therapeutics, US Food and Drug Administration, Silver Spring, Maryland

Publisher

American Medical Association (AMA)

Subject

Pediatrics, Perinatology and Child Health

Reference54 articles.

1. Developmental pharmacology—drug disposition, action, and therapy in infants and children.;Kearns;N Engl J Med,2003

2. Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity.;Allegaert;Br J Anaesth,2005

3. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature.;Ginsberg;Toxicol Sci,2002

4. Pharmacokinetic and pharmacodynamic basis for effective argatroban dosing in pediatrics.;Madabushi;J Clin Pharmacol,2011

5. Pharmacokinetics of zidovudine in infants: a population analysis across studies.;Mirochnick;Clin Pharmacol Ther,1999

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and In vivo Evaluation of Atomoxetine Hydrochloride ODMTs in a Nicotine-induced Attention Deficit Hyperactivity Disorder (ADHD) Model in Rats;AAPS PharmSciTech;2024-07-31

2. Pediatric Pharmacology for the Primary Care Provider: Advances and Limitations;Pediatrics;2024-06-06

3. Nicotinamide adenine dinucleotide treatment confers resistance to neonatal ischemia and hypoxia: effects on neurobehavioral phenotypes;Neural Regeneration Research;2024-03-01

4. Publication Practices Among Pivotal Clinical Trials of High-Risk Medical Devices;IFMBE Proceedings;2023-09-14

5. Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010–2020: A Cross-Sectional Study;Therapeutic Innovation & Regulatory Science;2023-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3